257 related articles for article (PubMed ID: 15587919)
21. Receptor-mediated endocytosis and intracellular trafficking of lipoproteins and transferrin in insect cells.
Van Hoof D; Rodenburg KW; Van der Horst DJ
Insect Biochem Mol Biol; 2005 Feb; 35(2):117-28. PubMed ID: 15681222
[TBL] [Abstract][Full Text] [Related]
22. Release of the soluble transferrin receptor is directly regulated by binding of its ligand ferritransferrin.
Dassler K; Zydek M; Wandzik K; Kaup M; Fuchs H
J Biol Chem; 2006 Feb; 281(6):3297-304. PubMed ID: 16354665
[TBL] [Abstract][Full Text] [Related]
23. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice.
Yhee JY; Lee SJ; Lee S; Song S; Min HS; Kang SW; Son S; Jeong SY; Kwon IC; Kim SH; Kim K
Bioconjug Chem; 2013 Nov; 24(11):1850-60. PubMed ID: 24107100
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the potential of transferrin-adriamycin conjugates in the treatment of bladder cancer.
Munns J; Yaxley J; Coomer J; Lavin MF; Gardiner RA; Watters D
Br J Urol; 1998 Aug; 82(2):284-9. PubMed ID: 9722768
[TBL] [Abstract][Full Text] [Related]
25. Absence of binding between the human transferrin receptor and the transferrin complex of biological toxic trace element, aluminum, because of an incomplete open/closed form of the complex.
Sakajiri T; Yamamura T; Kikuchi T; Ichimura K; Sawada T; Yajima H
Biol Trace Elem Res; 2010 Sep; 136(3):279-86. PubMed ID: 19859668
[TBL] [Abstract][Full Text] [Related]
26. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
Gurdag S; Khandare J; Stapels S; Matherly LH; Kannan RM
Bioconjug Chem; 2006; 17(2):275-83. PubMed ID: 16536456
[TBL] [Abstract][Full Text] [Related]
27. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
28. Generation of the soluble transferrin receptor requires cycling through an endosomal compartment.
Rutledge EA; Green FA; Enns CA
J Biol Chem; 1994 Dec; 269(50):31864-8. PubMed ID: 7989360
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the defect in a variant of HL-60 promyelocytic leukemia cells with reduced transferrin receptor expression.
Ishiguro K; Ho PT; Sartorelli AC
Somat Cell Mol Genet; 1992 Jan; 18(1):45-63. PubMed ID: 1546369
[TBL] [Abstract][Full Text] [Related]
30. Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate.
Li S; Zhao H; Mao X; Fan Y; Liang X; Wang R; Xiao L; Wang J; Liu Q; Zhao G
Pharm Res; 2019 Oct; 36(12):168. PubMed ID: 31654226
[TBL] [Abstract][Full Text] [Related]
31. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells.
Daniels TR; Delgado T; Helguera G; Penichet ML
Clin Immunol; 2006 Nov; 121(2):159-76. PubMed ID: 16920030
[TBL] [Abstract][Full Text] [Related]
32. Transferrin conjugated poly (γ-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery.
Zhao C; Liu X; Liu J; Yang Z; Rong X; Li M; Liang X; Wu Y
Colloids Surf B Biointerfaces; 2014 Nov; 123():787-96. PubMed ID: 25454663
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
34. The transepithelial transport of a G-CSF-transferrin conjugate in Caco-2 cells and its myelopoietic effect in BDF1 mice.
Widera A; Bai Y; Shen WC
Pharm Res; 2004 Feb; 21(2):278-84. PubMed ID: 15032309
[TBL] [Abstract][Full Text] [Related]
35. Endocytosis of a functionally enhanced GFP-tagged transferrin receptor in CHO cells.
He Q; Sun X; Chu C; Jiang Q; Zhu H; He Y; Yue T; Wang R; Lei P; Shen G
PLoS One; 2015; 10(3):e0122452. PubMed ID: 25803700
[TBL] [Abstract][Full Text] [Related]
36. Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins.
Yoon DJ; Chu DS; Ng CW; Pham EA; Mason AB; Hudson DM; Smith VC; MacGillivray RT; Kamei DT
J Control Release; 2009 Feb; 133(3):178-84. PubMed ID: 18992290
[TBL] [Abstract][Full Text] [Related]
37. Mechanism for multiple ligand recognition by the human transferrin receptor.
Giannetti AM; Snow PM; Zak O; Björkman PJ
PLoS Biol; 2003 Dec; 1(3):E51. PubMed ID: 14691533
[TBL] [Abstract][Full Text] [Related]
38. Active tumor-targeted delivery of PEG-protein via transferrin-transferrin-receptor system.
Jiang Y; Tang G; Hong M; Zhu S; Fang C; Shi B; Pei Y
J Drug Target; 2007 Dec; 15(10):672-83. PubMed ID: 18041635
[TBL] [Abstract][Full Text] [Related]
39. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
[TBL] [Abstract][Full Text] [Related]
40. In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells.
Wängler C; Nada D; Höfner G; Maschauer S; Wängler B; Schneider S; Schirrmacher E; Wanner KT; Schirrmacher R; Prante O
Mol Imaging Biol; 2011 Apr; 13(2):332-41. PubMed ID: 20473573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
